Figure 1.

Treatment schema for CCG-2961 and schedule of interleukin-2 (IL-2) infusions (inset) and sampling for serum IL-2 receptor (block arrows). IdaCTER is idarubicin, cytarabine, thioguanaine, etoposide, and rubidomycin (daunorubicin), HidAC is High dose Ara-C, L-asp is L-asparaginase and R is randomization.